ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.
Lung Cancer Gets Less Press, Study Finds
Vanderbilt Wins Lung Cancer SPORE Grant.
Vanderbilt, Jonsson Centers Win NCI SPORE Grants.
Prevention Trials Should Get More Funding, Coltman Says.
FDA Approves Gleevec In 73 Days, A Speed Record.
Pesticides Not Linked To High Rates Of Breast Cancer.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?









